首頁教學〉專題討論

專題討論

專題年度:
共 83 頁(1643筆)  上一頁  第   頁 下一頁   
日期 學生 標題 老師
2005/10/14
17:10-18:00
翁汶燦 RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines (Cancer Res., 65:7455-7461, 15 August 2005) 賴明德
2005/10/14
16:00-16:50
黃議賢 Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling (Cancer Cell, 8:13-23, July 2005) 湯銘哲
2005/10/14
15:10-16:00
吳明恒 Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion (Cell, 121:335-348, 6 May 2005) 張 玲
2005/10/11
17:10-18:00
莊懷佳 PDK1 nucleates T cell receptor-induced signaling complex for NF-B activation (Science, 308:114-118, 1 April 2005) 林以行
2005/10/11
16:00-16:50
林裕萍 The autoimmune suppressor Gadd45 inhibits the T cell alternative p38 activation pathway (Nature Immunology, 6:396-402, April 2005) 林以行
2005/10/11
15:10-16:00
萬書彣 (英) Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice (Nature Medicine, 11:491-498, May 2005) 謝奇璋
2005/10/07
15:10-18:00
王昊宸 Activation of RalA is critical for Ras-induced tumorigenesis of human cells (Cancer Cell, 7:533-545, June 2005) 劉校生
2005/10/07
16:00-16:50
許芸燕 CUTL1 is a target of TGF signaling that enhances cancer cell motility and invasiveness (Cancer Cell, 7:521-532, June 2005) 鄭宏祺
2005/10/07
15:10-16:00
郭承翔 PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells (Cell, 120:303-313, 11 February 2005) 張 玲
2005/10/04
17:10-18:00
黃文彥 CD70+ antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa (Nature Immunology, 6:698-706, July 2005) 林以行
2005/10/04
16:00-16:50
李峻瑋 Transforming growth factor- controls T helper type 1 cell development through regulation of natural killer cell interferon- (Nature Immunology, 6:600-607, June 2005) 凌 斌
2005/10/04
15:10-16:00
李一平 A critical function for type 1 interferons in cancer immunoediting (Nature Immunology, 6:722-729, July 2005) 黎煥耀
2005/09/30
17:10-18:00
吳金漢 RalGDS is required for tumor formation in a model of skin carcinogenesis (Cancer Cell, 7:219-226, March 2005) 凌斌
2005/09/30
16:00-16:50
葉碧雯 Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis (Nature, 436:725-730, 4 August 2005) 張敏政
2005/09/30
15:10-16:00
黃冠誠 Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants (Nature, 436:807-811, 11 August 2005) 張敏政
2005/09/27
17:10-18:00
陳韻如 Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3 (Nature Immunology, 6:777-784, August 2005) 徐麗君
2005/09/27
16:00-16:50
鄒志成 Gp96 is a receptor for a novel Listeria monocytogenes virulence factor, Vip, a surface protein (The EMBO J., 24:2827-2838, 2005 何漣漪
2005/09/27
15:10-16:00
楊亞倫(英) Sexual reproduction between partners of the same mating type in Cryptococcus neoformans (Nature, 434:1017-1021, 21 April 2005) 許明隆
2005/09/23
17:10-18:00
王怡文 Inhibition of indoleamine 2,3-dioxygenase, and immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy (Nature Medicine, 11:312-319, March 2005) 賴明德
2005/09/23
16:00-16:50
顏孟畿 Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo (Nature Medicine, 11:130-137, February 2005) 林以行

1 |  2 |  3 |  4 |  5 |  6 |  7 |  8 |  9 |  10 |  11 |  12 |  13 |  14 |  15 |  16 |  17 |  18 |  19 |  20 |  21 |  22 |  23 |  24 |  25 |  26 |  27 |  28 |  29 |  30 |  31 |  32 |  33 |  34 |  35 |  36 |  37 |  38 |  39 |  40 |  41 |  42 |  43 |  44 |  45 |  46 |  47 |  48 |  49 |  50 |  51 |  52 |  53 |  54 |  55 |  56 |  57 |  58 |  59 |  60 |  61 |  62 |  63 |  64 |  65 |  66 |  67 |  68 |  69 |  70 |  71 |  72 |  73 |  74 |  75 |  76 |  77 |  78 |  79 |  80 |  81 |  82 |  83 |